Document Detail


Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome.
MedLine Citation:
PMID:  21332711     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hepcidin is a major regulator of iron metabolism. We evaluated changes in serum hepcidin during 3 months of therapy with the iron-chelator deferasirox in patients with low-risk myelodysplastic syndrome and iron overload. Serum hepcidin was found to be high in these patients, correlated with their iron and oxidative status, and further increased by treatment with deferasirox. These findings support the concept that the hepcidin level represents a balance between the stimulating effect of iron overload and the inhibitory effects of erythropoietic activity and oxidative stress. These preliminary findings favour the rationale for iron chelation therapy in such patients.
Authors:
Hussam Ghoti; Eitan Fibach; Mark Westerman; Olbina Gordana; Tomas Ganz; Eliezer A Rachmilewitz
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-20
Journal Detail:
Title:  British journal of haematology     Volume:  -     ISSN:  1365-2141     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Blackwell Publishing Ltd.
Affiliation:
Department of Haematology, Edith Wolfson Medical Centre, Holon Department of Haematology, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel Intrinsic LifeSciences LLC, La Jolla Department of Medicine, David Geffen School of Medicine, Los Angeles, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.
Next Document:  l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in ch...